These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22075380)

  • 21. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor of growth 4 induces growth suppression and apoptosis in glioma U87MG.
    Li X; Cai L; Chen H; Zhang Q; Zhang S; Wang Y; Dong Y; Cheng H; Qi J
    Pathobiology; 2009; 76(4):181-92. PubMed ID: 19571607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma.
    Yin S; Goodrich DW
    Int J Oncol; 2006 Mar; 28(3):781-5. PubMed ID: 16465385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal model.
    Pan X; Sheng W; Zhu Q; Xie Y; Ye Z; Xiang J; Li D; Yang J
    Cancer Biother Radiopharm; 2008 Aug; 23(4):425-34. PubMed ID: 18771346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo.
    Cao L; Chen S; Zhang C; Chen C; Lu N; Jiang Y; Cai Y; Yin Y; Xu J
    Int J Clin Exp Pathol; 2015; 8(3):2919-27. PubMed ID: 26045800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK/GCV gene therapy.
    Liu SH; Davis A; Li Z; Ballian N; Davis E; Wang XP; Fisher W; Brunicardi FC
    J Surg Res; 2007 Jul; 141(1):45-52. PubMed ID: 17512546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular target-based therapy of pancreatic cancer.
    Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
    Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ad-ING4 inhibits K562 cell growth].
    Yu X; Zhang HF; Wang JZ; Xie YF; Yang JC; Miao JC
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):396-400. PubMed ID: 17939406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1.
    Li J; Li G
    Cancer Res; 2010 Dec; 70(24):10445-53. PubMed ID: 21056991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells.
    Abdelrahim M; Smith R; Burghardt R; Safe S
    Cancer Res; 2004 Sep; 64(18):6740-9. PubMed ID: 15374992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of ING4 in human melanoma cell migration, invasion and patient survival.
    Li J; Martinka M; Li G
    Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
    Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
    Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth.
    Pan XT; Zhu QY; Li DC; Yang JC; Zhang ZX; Zhu XG; Zhao H
    Chin Med J (Engl); 2008 Oct; 121(20):2031-6. PubMed ID: 19080270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
    Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
    Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
    Furukawa K; Ohashi T; Haruki K; Fujiwara Y; Iida T; Shiba H; Uwagawa T; Kobayashi H; Yanaga K
    Cancer Lett; 2011 Jul; 306(1):92-8. PubMed ID: 21482023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer.
    Kovacevic Z; Chikhani S; Lovejoy DB; Richardson DR
    Mol Pharmacol; 2011 Oct; 80(4):598-609. PubMed ID: 21719465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
    Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma.
    Zhou Y; Song X; Jia R; Wang H; Dai L; Xu X; Gu P; Ge S; Fan X
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):661-74. PubMed ID: 20546535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.